Clinical Trial Update: Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

View source ↗

Summary

A real-world study evaluating edoxaban use in patients with non-valvular atrial fibrillation in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Non-valvular Atrial Fibrillation | Status: COMPLETED